Bartalena L, Bogazzi F, Pinchera A
Istituto di Endocrinologia, Università degli Studi, Pisa.
Ann Ist Super Sanita. 1991;27(3):531-9.
Since many tests to investigate thyroid function are currently available, appropriate selection is required to limit the number of assay needed to establish the correct diagnosis of thyroid dysfunction. The limitations inherent in the different tests, and the interferences caused by nonthyroidal factors, especially drugs, must, therefore, be taken into account. Serum total thyroid hormone (TT4 and TT3) determinations are largely affected by changes in the concentrations of thyroid hormone transport proteins (mainly T4-binding globulin). Thus, in many cases, serum TT4 and TT3 measurements do not reliably establish thyroid status. Serum free thyroid hormone (FT4 and FT3) concentrations are independent of transport proteins and more appropriately reflect thyroid status. Serum FT3 measurement is more appropriate for the diagnosis of hyperthyroidism and drug-overdosage in L-T4-treated patients. Conversely, serum FT4 measurement more correctly identifies hypothyroid patients. Serum TSH determination by the currently available sensitive (low detection limit) assays constitutes an indispensable complementary test in both conditions.
由于目前有许多用于检测甲状腺功能的试验,因此需要进行适当选择,以限制为正确诊断甲状腺功能障碍所需的检测数量。因此,必须考虑不同检测方法固有的局限性以及非甲状腺因素(尤其是药物)所造成的干扰。血清总甲状腺激素(TT4和TT3)测定在很大程度上受甲状腺激素转运蛋白(主要是T4结合球蛋白)浓度变化的影响。因此,在许多情况下,血清TT4和TT3测量不能可靠地确定甲状腺状态。血清游离甲状腺激素(FT4和FT3)浓度与转运蛋白无关,更能准确反映甲状腺状态。血清FT3测量对于诊断L-T4治疗患者的甲状腺功能亢进和药物过量更为合适。相反,血清FT4测量能更准确地识别甲状腺功能减退患者。通过目前可用的灵敏(低检测限)检测方法测定血清TSH,在这两种情况下都是不可或缺的补充检测。